Derek Small
Director/Board Member at INNOVIVA, INC.
Profile
Derek A.
Small is the founder and has held multiple positions throughout his career.
He founded Luson Bioventures LLC in 2007 and serves as the Managing Director.
In 2011, he founded Monument Biosciences, Inc. and holds the position of Chairman & Chief Executive Officer.
In 2012, he co-founded Assembly Pharmaceuticals, Inc. and served as the Executive Chairman & Chief Executive Officer.
In 2014, he co-founded Assembly Biosciences, Inc. and held the position of Director.
In 2018, he founded Gate Neurosciences, Inc. and serves as the Executive Chairman.
Currently, Mr. Small holds positions at Anagin, Inc. as a Director, Innoviva, Inc. as an Independent Director starting in 2024, and BioCrossroads as a Board Member starting in 2017.
In the past, Mr. Small has worked at EndGenitor Technologies, Inc. as an Advisor & CEO from 2007 to 2009.
He also served as the President, Chief Executive Officer & Director of Naurex, Inc. from 2012 to 2014.
From 2008 to 2011, he held the positions of President, Chief Executive Officer & Director at BlinkBio, Inc. He was also the President, Chief Executive Officer & Director of BlinkBio, Inc. from 2009 to 2012.
Additionally, he has held positions at Simdesk Technologies, Inc. as a Director-Strategic Alliances, Semafore Pharmaceuticals, Inc. as the Head-Business Development & Regulatory Affairs, and Kinagen, Inc. as an Advisor.
Mr. Small's education includes an undergraduate degree from Franklin College of Indiana, Inc. and Harlaxton College.
Derek Small active positions
| Companies | Position | Start |
|---|---|---|
| INNOVIVA, INC. | Director/Board Member | 28/04/2024 |
Gate Neurosciences, Inc.
 Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Gate Neurosciences, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Carmel, IN. | Founder | 20/11/2018 |
Anagin, Inc.
 Anagin, Inc. Pharmaceuticals: MajorHealth Technology Anagin, Inc. develops targeted therapies for pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. It targeted diseases such as post traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, neuropathic pain, Alzheimer’s disease and Parkinson’s disease. The company was founded by Anatha Shekhar and Yvonne Lai in 2013 and is headquartered in Indianapolis, IN. | Director/Board Member | - |
BioCrossroads
 BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Director/Board Member | 30/06/2017 |
Luson Bioventures LLC
 Luson Bioventures LLC Investment ManagersFinance Luson Bioventures LLC operates as an biotechnology and biopharmaceutical venture creation firm. The company was founded by Derek A. Small in 2007 and is headquartered in Zionsville, IN. | Founder | 31/12/2006 |
Former positions of Derek Small
| Companies | Position | End |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Chief Executive Officer | 05/08/2019 |
BlinkBio, Inc.
 BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Chief Executive Officer | 31/03/2012 |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Chief Executive Officer | 29/06/2011 |
EndGenitor Technologies, Inc.
 EndGenitor Technologies, Inc. BiotechnologyHealth Technology EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN. | Chief Executive Officer | 20/03/2009 |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Derek Small
| Harlaxton College | Undergraduate Degree |
| Franklin College of Indiana, Inc. | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Simdesk Technologies, Inc.
 Simdesk Technologies, Inc. Packaged SoftwareTechnology Services SimDesk Technologies, Inc. provided web based software solutions and services. Its software products were used for desktop applications such as word processing, spreadsheets, printing, and e-mail management. The firm offered services to the government agencies and educational institutions. The company was founded by Ray C. Davis in 1999 and was headquartered in Houston, TX. | Technology Services |
EndGenitor Technologies, Inc.
EndGenitor Technologies, Inc. BiotechnologyHealth Technology EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN. | Health Technology |
Semafore Pharmaceuticals, Inc.
 Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Retail Trade |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |
BlinkBio, Inc.
BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology BlinkBio, Inc. operates as a biotechnology company. It develops medicines for the treatment of cancer and other diseases. The company was founded by Maneesh Pingle, Francis Barany, Don Bergstrom and Michael Gargano in 2009 and is headquartered in Juno Beach, FL. | Health Technology |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Finance |
Luson Bioventures LLC
Luson Bioventures LLC Investment ManagersFinance Luson Bioventures LLC operates as an biotechnology and biopharmaceutical venture creation firm. The company was founded by Derek A. Small in 2007 and is headquartered in Zionsville, IN. | Finance |
| Kinagen, Inc. | |
Assembly Pharmaceuticals, Inc.
 Assembly Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Assembly Pharmaceuticals, Inc. manufactures and supplies biopharmaceutical products. The company was founded on August 8, 2013 and is headquartered in San Francisco, CA. | Health Technology |
Anagin, Inc.
Anagin, Inc. Pharmaceuticals: MajorHealth Technology Anagin, Inc. develops targeted therapies for pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. It targeted diseases such as post traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, neuropathic pain, Alzheimer’s disease and Parkinson’s disease. The company was founded by Anatha Shekhar and Yvonne Lai in 2013 and is headquartered in Indianapolis, IN. | Health Technology |
Gate Neurosciences, Inc.
Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Gate Neurosciences, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Carmel, IN. | Health Technology |
- Stock Market
- Insiders
- Derek Small
